AL-39324
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-39324, covering 2014-07-18 to 2014-07-18. Get the full timeline:
Most recent: Clinical Trial Update: WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination [Phase 2]